Nxera Settles Patent Fight After Rival Admits Infringement
Biopharma business Nxera has settled its dispute over engineered proteins after a rival admitted it had infringed two of Nxera's patents covering cell membrane stabilizers that are used in drug discovery...To view the full article, register now.
Already a subscriber? Click here to view full article